Company Leverages More Than Twenty Years of Drug Response Data Derived from Massive Biobank of Live Cell Tumor ...

We recently published a list of Jim Cramer Reveals “Quiet” Stock That Goes Up In This List Of 12 Stocks. In this article, we ...

Regeneron has been busy, with two health tech deals announced this week: One is about genetic data and one about AI. Both of ...

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction ...

Regeneron said it will acquire 23andMe’s genomics service and its bank of 15 million customers’ personal and genetic data as ...

Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, ...

The proposed transaction with Regeneron includes 23andMe’s personal genome service and total health and research services.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Me gene privacy question takes a turn in bankruptcy Why a big AI player wants a quarter-million bucks from 23andMe Why a big ...

Huang’s comments came as the truce between the U.S. and China over tariffs and semiconductors continues to be delicate.

Also see: 23andMe users alerted they may want to delete ... for ‘white genocide’ glitches How Apple fell behind in the AI race Victims of explicit deepfakes will soon be able to take legal ...

23andMe has faced an uncertain future for some ... House Republicans include a 10-year ban on US states regulating AI in ‘big, beautiful’ bill The proposed transaction with Regeneron includes ...